COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland. (2022)
Attributed to:
Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7189/jogh.12.05025
PubMed Identifier: 35802764
Publication URI: http://europepmc.org/abstract/MED/35802764
Type: Journal Article/Review
Volume: 12
Parent Publication: Journal of global health
ISSN: 2047-2978